- Article
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
- Antonino Lupica,
- Vincenzo Di Stefano,
- Salvatore Iacono,
- Antonia Pignolo,
- Martina Quartana,
- Andrea Gagliardo,
- Brigida Fierro and
- Filippo Brighina
Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these pat...

